Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 28, 2007

View Archived Issues

Recent patents impart new therapeutic agents for respiratory and allergic disorders

Novel therapeutic agents for cardiovascular disorders imparted by pSivida

Novel 5-HT2C antagonist developed at BMS for the treatment of obesity

Recent patents report new treatments for neuropsychiatric disorders

New treatment option for urological disorders reported by Takeda

Mepolizumab lowers blood eosinophils and reduces steroid use in hypereosinophilic syndrome

Icatibant effective in acute hereditary angioedema attacks

Andolast prevents bronchoconstriction in asthma patients

BioMarin recaps Q4 events

NextPharma signs development agreement with Eucodis

Plethora plans phase III program for Invicorp in erectile dysfunction

VGX Pharmaceuticals and Advisys sign merger agreement

Progress in Avalon and Novartis' drug discovery collaboration

Lilly plans new phase III trial of Xigris

Enrollment open in phase III study of Stimuvax for NSCLC

Merck KGaA holds nearly all voting rights in Merck Serono

Ortec begins PMA supplement filing for OrCel

Amazon Biotech preparing phase I/II studies for AMZ-0026

Bristol-Myers Squibb and Adnexus to develop oncology compounds

Novelix licenses NVX-207 to AOP Orphan

Trius acquires rights to Dong-A's oxazolidinone antibacterial compounds

Phase III study of glufosfamide in pancreatic cancer misses endpoint

Positive phase I findings for LCP-AtorFen

Takeda and TAP sign promotion agreement for Amitiza

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...